Skip to main content

Table 3 Pairwise comparisons between the three groups in the continuous outcomes

From: Comparative study between oxytocin and combination of tranexamic acid and ethamsylate in reducing intra-operative bleeding during emergency and elective cesarean section after 38 weeks of normal pregnancy

Pairwise Comparisons

Dependent Variable

(I) Technique done

(J) Technique done

Mean Difference (I-J)

Std. Error

P – Value b

95% Confidence Interval for Difference

Lower Bound

Upper Bound

Operative time

Oxytocin

Tranexamic acid with ethamsylate

0.353

2.782

1.000

-6.346

7.052

Saline

0.071

2.810

1.000

-6.697

6.839

Tranexamic acid with ethamsylate

Oxytocin

-0.353

2.782

1.000

-7.052

6.346

Saline

-0.282

2.662

1.000

-6.692

6.128

Saline

Oxytocin

-0.071

2.810

1.000

-6.839

6.697

Tranexamic acid with ethamsylate

0.282

2.662

1.000

-6.128

6.692

Blood Loss

Oxytocin

Tranexamic acid with ethamsylate

21.499

23.650

1.000

-35.453

78.452

Saline

-43.414

23.892

0.211

-100.951

14.122

Tranexamic acid with ethamsylate

Oxytocin

-21.499

23.650

1.000

-78.452

35.453

Saline

-64.914a

22.629

0.013

-119.407

-10.420

Saline

Oxytocin

43.414

23.892

0.211

-14.122

100.951

Tranexamic acid with ethamsylate

64.914a

22.629

0.013

10.420

119.407

Preoperative HB

Oxytocin

Tranexamic acid with ethamsylate

-0.043

0.122

1.000

-0.336

0.250

Saline

-0.137

0.123

0.800

-0.433

0.159

Tranexamic acid with ethamsylate

Oxytocin

0.043

0.122

1.000

-0.250

0.336

Saline

-0.094

0.116

1.000

-0.374

0.187

Saline

Oxytocin

0.137

0.123

0.800

-0.159

0.433

Tranexamic acid with ethamsylate

0.094

0.116

1.000

-0.187

0.374

Preoperative HCT

Oxytocin

Tranexamic acid with ethamsylate

-0.129

0.368

1.000

-1.015

0.757

Saline

-0.541

0.372

0.439

-1.436

0.354

Tranexamic acid with ethamsylate

Oxytocin

0.129

0.368

1.000

-0.757

1.015

Saline

-0.412

0.352

0.727

-1.260

0.435

Saline

Oxytocin

0.541

0.372

0.439

-0.354

1.436

Tranexamic acid with ethamsylate

0.412

0.352

0.727

-0.435

1.260

Postoperative HB

Oxytocin

Tranexamic acid with ethamsylate

-0.039

0.186

1.000

-0.485

0.408

Saline

-0.098

0.187

1.000

-0.549

0.354

Tranexamic acid with ethamsylate

Oxytocin

0.039

0.186

1.000

-0.408

0.485

Saline

-0.059

0.177

1.000

-0.486

0.368

Saline

Oxytocin

0.098

0.187

1.000

-0.354

0.549

Tranexamic acid with ethamsylate

0.059

0.177

1.000

-0.368

0.486

Postoperative HCT

Oxytocin

Tranexamic acid with ethamsylate

-0.203

0.607

1.000

-1.663

1.258

Saline

0.135

0.613

1.000

-1.341

1.611

Tranexamic acid with ethamsylate

Oxytocin

0.203

0.607

1.000

-1.258

1.663

Saline

0.338

0.580

1.000

-1.060

1.735

Saline

Oxytocin

-0.135

0.613

1.000

-1.611

1.341

Tranexamic acid with ethamsylate

-0.338

0.580

1.000

-1.735

1.060

Change in HB

Oxytocin

Tranexamic acid with ethamsylate

0.004

0.171

1.000

-0.406

0.415

Saline

0.039

0.172

1.000

-0.376

0.454

Tranexamic acid with ethamsylate

Oxytocin

-0.004

0.171

1.000

-0.415

0.406

Saline

0.035

0.163

1.000

-0.358

0.428

Saline

Oxytocin

-0.039

0.172

1.000

-0.454

0.376

Tranexamic acid with ethamsylate

-0.035

0.163

1.000

-0.428

0.358

Change in HCT

Oxytocin

Tranexamic acid with ethamsylate

-0.074

0.595

1.000

-1.507

1.359

Saline

0.676

0.601

0.785

-0.772

2.124

Tranexamic acid with ethamsylate

Oxytocin

0.074

0.595

1.000

-1.359

1.507

Saline

0.750

0.569

0.567

-0.621

2.121

Saline

Oxytocin

-0.676

0.601

0.785

-2.124

0.772

Tranexamic acid with ethamsylate

-0.750

0.569

0.567

-2.121

0.621

Postoperative Hospital Stay

Oxytocin

Tranexamic acid with ethamsylate

-0.073

0.312

1.000

-0.824

0.678

Saline

0.076

0.315

1.000

-0.682

0.835

Tranexamic acid with ethamsylate

Oxytocin

0.073

0.312

1.000

-0.678

0.824

Saline

0.149

0.298

1.000

-0.570

0.868

Saline

Oxytocin

-0.076

0.315

1.000

-0.835

0.682

Tranexamic acid with ethamsylate

-0.149

0.298

1.000

-0.868

0.570

  1. Table 3 shows the details of the pairwise comparison between the three groups in the continuous outcomes adjusted to the parity, previous CS, CS type, and the indication of CS
  2. Based on estimated marginal means
  3. HB Hemoglobin, HCT Hematocrit
  4. aThe mean difference is significant at the 0.05 level
  5. bAdjustment for multiple comparisons: Bonferroni